Anticardiolipin antibodies are an independent risk factor for first ischemic stroke. The Antiphospholipid Antibodies in Stroke Study (APASS) Group
- PMID: 8413969
- DOI: 10.1212/wnl.43.10.2069
Anticardiolipin antibodies are an independent risk factor for first ischemic stroke. The Antiphospholipid Antibodies in Stroke Study (APASS) Group
Abstract
We evaluated 255 consecutive first ischemic stroke patients and 255 age-/sex-matched hospitalized nonstroke patients at 15 medical centers for anticardiolipin antibodies (aCL). Sera were obtained within 7 days of stroke onset (cases) or hospital admission (controls) and stored at -20 degrees C until the aCL level was determined at a central laboratory. Results were read as negative, low, moderate, or high positive based on standardized optical density values. We recorded clinical, laboratory, and radiologic data without knowledge of antibody status. A positive aCL level was present in 9.7% of stroke patients and 4.3% of controls. The odds ratio for stroke status, given aCL positivity, was 2.31 after adjustment for age, ethnicity, gender, hypertension, diabetes mellitus, coronary artery disease, and cigarette smoking. Thus the frequency of aCL is significantly increased in these patients with first ischemic stroke. Further, aCL appear to be an independent risk factor for stroke in these patients.
Similar articles
-
Elevated anticardiolipin antibody titer is a stroke risk factor in a multiethnic population independent of isotype or degree of positivity.Stroke. 1999 Aug;30(8):1561-5. doi: 10.1161/01.str.30.8.1561. Stroke. 1999. PMID: 10436101
-
Anticardiolipin antibodies are not an independent risk factor for stroke: an incident case-referent study nested within the MONICA and Västerbotten cohort project.Stroke. 2000 Jun;31(6):1289-93. doi: 10.1161/01.str.31.6.1289. Stroke. 2000. PMID: 10835446
-
Specificity, isotype, and titer distribution of anticardiolipin antibodies in CNS diseases.Neurology. 1998 Nov;51(5):1376-80. doi: 10.1212/wnl.51.5.1376. Neurology. 1998. PMID: 9818863
-
Anticardiolipin antibodies in ischemic stroke in the young: Indian experience.J Neurol Sci. 1997 Sep 10;150(2):137-42. doi: 10.1016/s0022-510x(97)00071-3. J Neurol Sci. 1997. PMID: 9268241
-
Anticardiolipin antibodies and recurrent coronary events: a prospective study of 1150 patients. Thrombogenic Factors, and Recurrent Coronary Events Investigators.Circulation. 2000 Sep 12;102(11):1258-63. doi: 10.1161/01.cir.102.11.1258. Circulation. 2000. PMID: 10982540
Cited by
-
Screening for hypercoagulable syndromes following stroke.Curr Atheroscler Rep. 2003 Jul;5(4):291-8. doi: 10.1007/s11883-003-0052-8. Curr Atheroscler Rep. 2003. PMID: 12793970 Review.
-
Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association.Stroke. 2014 Dec;45(12):3754-832. doi: 10.1161/STR.0000000000000046. Epub 2014 Oct 28. Stroke. 2014. PMID: 25355838 Free PMC article.
-
Thromboembolic risk in patients with high titre anticardiolipin and multiple antiphospholipid antibodies.Thromb Haemost. 2003 Jul;90(1):108-15. Thromb Haemost. 2003. PMID: 12876633 Free PMC article.
-
Antiphospholipid syndrome.J R Soc Med. 2002 Jul;95(7):336-42. doi: 10.1177/014107680209500705. J R Soc Med. 2002. PMID: 12091507 Free PMC article. Review. No abstract available.
-
Antiphospholipid antibodies in young adults with stroke.J Thromb Thrombolysis. 2005 Oct;20(2):105-12. doi: 10.1007/s11239-005-3204-6. J Thromb Thrombolysis. 2005. PMID: 16205859 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
